###begin article-title 0
Fragile X Syndrome in Korea: A Case Series and a Review of the Literature
###end article-title 0
###begin p 1
###xml 572 576 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 674 678 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 342 350 <span type="species:ncbi:9606">children</span>
###xml 592 600 <span type="species:ncbi:9606">children</span>
###xml 615 619 <span type="species:ncbi:9606">boys</span>
###xml 648 651 <span type="species:ncbi:9606">boy</span>
###xml 725 733 <span type="species:ncbi:9606">children</span>
###xml 863 867 <span type="species:ncbi:9606">boys</span>
###xml 984 988 <span type="species:ncbi:9606">boys</span>
The purposes of this study were to present DNA analysis findings of our case series of fragile X syndrome (FXS) based on methylation-specific polymerase chain reaction (MS-PCR), PCR, and Southern blotting alongside developmental characteristics including psychological profiles and to review the literature on FXS in Korea. The reports of 65 children (male:female, 52:13; age, 6.12+/-4.00 yrs) referred for the diagnosis of FXS over a 26-months period were retrospectively reviewed for the identification of full mutation or premutation of fragile X mental retardation 1 (FMR1). Among the 65 children, there were 4 boys with full mutation, and one boy showed premutation of FMR1, yielding a 6.15% positive rate of FXS. All 4 children with full mutation showed significant developmental delay, cognitive dysfunction, and varying degrees of autistic behaviors. The boys with premutation showed also moderate mental retardation, severe drooling, and behavioral problems as severe as the boys with full mutation. Thirteen articles on FXS in Korea have been published since 1993, and they were reviewed. The positive rate of FXS was in the range of 0.77-8.51%, depending on the study groups and the method of diagnosis. Finally, the population-based prevalence study on FXS in Korea is required in the near future.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 364 368 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 416 420 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 637 641 635 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1089 1097 <span type="species:ncbi:9606">children</span>
Fragile X syndrome (FXS) is the most common cause of inherited mental retardation and the second most common cause of genetically associated mental retardation following trisomy 21 (1). FXS is caused by a dynamic mutation which involves an unstable expansion of a trinucleotide CGG repeat at the 5'-untranslated region (UTR) of the fragile X mental retardation 1 (FMR1) gene, located at Xq27.3. The silencing of the FMR1 gene leads to the deficiency of the fragile X mental retardation protein (FMRP), thus causing the classical FXS. The population-based prevalence study of full mutation (CGG>/=200 repeats and cytosine methylation) of FMR1 through DNA analysis was estimated 1/4,000 males and 1 in 8,000 females. Furthermore, there have been growing evidences of premutation (55-200 CGG repeats)-associated clinical phenotypes such as milder forms of FXS including autistic features, developmental delay and latter phenotypes of fragile X tremor ataxia syndrome, and premature ovarian failure. Considering the prevalence of full mutation and premutation as well as their consequences on children's development and their latter phenotypes, the impact of FXS is thought to be much more enormous than what has earlier been thought.
###end p 3
###begin p 4
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
There have been growing interests worldwide on the molecular diagnosis and clinical experiences on FXS. At present, polymerase chain reaction (PCR) (2), methylation-specific PCR (MS-PCR) (3), and Southern blotting (4) are considered as the golden standard for the diagnosis of FXS. Several laboratories in South Korea recently embarked on the molecular studies of FXS, thus allowing much experience on FXS.
###end p 4
###begin p 5
To the best of our knowledge, reports on FXS in Korea had been relatively few, compared to those of western countries. Furthermore, there has been no report that MS-PCR was used for the diagnosis of FXS in Korea. The purposes of this study were to present DNA analysis findings of our case series of FXS based on MS-PCR, PCR, and Southern blotting alongside developmental characteristics including psychological profiles and to review the literature on FXS in Korea.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Case series
###end title 7
###begin p 8
###xml 82 90 <span type="species:ncbi:9606">children</span>
During the period of 26 months from March 2004 to May 2006, the DNA samples of 65 children (male:female, 52:13; age, 6.12+/-4.00 yr-old) were received at the Department of Medical Genetics, Ajou University Medical Center for the diagnosis of FXS. The main problems suggestive of FXS were developmental delay, cognitive dysfunction, and behavioral problems.
###end p 8
###begin p 9
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 287 291 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 350 354 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 422 426 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 555 559 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 633 637 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 852 853 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 128 132 <span type="species:ncbi:9606">boys</span>
###xml 359 363 <span type="species:ncbi:9606">boys</span>
###xml 502 507 <span type="species:ncbi:9606">girls</span>
The reports of these 65 cases were reviewed in order to identify either full mutation or premutation of FMR1. Full mutation for boys was diagnosed by the presence of methylated CpG island in the promoter of the FMR1 as well as the presence of large expansions (>/=200) of CGG repeats of FMR1 on the MS-PCR, PCR, and Southern blotting. Premutation of FMR1 for boys was diagnosed by the presence of 55-200 repeats of CGG in FMR1 and unmethylated CpG island on the MS-PCR, PCR, and Southern blotting. For girls, the status of full mutation or premutation of FMR1 was determined according to the results of PCR and Southern blotting for FMR1. It was based on the definition by American College of Medical Genetics in 2001 where the lower bound of the premutation range was 55 CGG repeats, irrespective of the nucleotide composition of the repeat sequence (5).
###end p 9
###begin p 10
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 240 248 <span type="species:ncbi:9606">children</span>
The phenotypic characteristics, such as age at diagnosis of FXS, gender, developmental characteristics, the presence of dysmorphic features, and brain MRI findings, were collected through a retrospective review of the medical charts of the children with full mutation or premutation of FMR1.
###end p 10
###begin p 11
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
The MS-PCR, PCR, and Southern blotting were used for FMR1, and the laboratory procedures were as follows.
###end p 11
###begin title 12
Methylation-specific PCR analysis
###end title 12
###begin p 13
###xml 455 459 455 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
The genomic DNA was extracted by the EZ DNA methylation kit (Zymo Research, Orange, CA, U.S.A.). For PCR amplification of the CpG island located upstream of the repeats, the following primers were used: FR690F: 5'-AAC GAC GAA CCG ACG ACG-3'and FR611R: 5'-CGT CGT CGC GTT GTC GTAC-3'. The primers were designed for the modified antisense strand and were specific for the amplification of the methylated C present in affected males and in the normal female FMR1 gene on the inactive X chromosome. PCR was modified and carried out as described previously (3).
###end p 13
###begin title 14
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
PCR amplification for CGG expansion region of FMR1
###end title 14
###begin p 15
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 652 656 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 838 842 834 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
Using the FXS kit (Abbott Laboratories, Abbott Park, IL, U.S.A.), amplification of the CGG repeat region of normal and premutated alleles in the FMR1 gene was carried out by PCR with a total volume of 10 microL, containing 20 ng of genomic DNA according to the manufacturer's protocols. The PCR-amplified products were resolved by electrophoresis on 1.5% agarose gels. To establish the fragment sizes of these products, the ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA, U.S.A.) was used. The Genescan software (Applied Biosystems) was used for accurate size calling and quantification of peak areas. The repeat number of CGG of FMR1 that could be analyzed by the ABI PRISM 3100 Genetic Analyzer was up to 230 repeats, whereas the electrophoresis on 1.5% agarose gels was used to identify 230-900 repeats of CGG of FMR1.
###end p 15
###begin title 16
Southern blot analysis
###end title 16
###begin p 17
###xml 603 604 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
Total genomic DNA was extracted from peripheral blood leukocytes by the salt-precipitation method, using Puregene kits (Gentra Systems, Inc., Minneapolis, MN, U.S.A.) and stored in a buffer, containing 10 mM Tris-HCl and 1 mM disodium EDTA, pH 8.0, at 4â„ƒ. Genomic DNA (15 microg) was digested with both EcoR I (100 U; New England Biolabs, Ipswich, MA, U.S.A.), and methylation-sensitive enzyme Eag I (50 U; New England Biolabs). Procedures were carried out, according to the procedures described in the Biotin Luminescent Detection kit (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD, U.S.A.) (4).
###end p 17
###begin title 18
Review of the literature
###end title 18
###begin p 19
The PubMed database (January 1969 to January 2007) and the KoreaMed (; January 1969 to January 2007) were searched to identify Korean reports on FXS with the key words, FXS and Korea.
###end p 19
###begin title 20
RESULTS
###end title 20
###begin title 21
Case series
###end title 21
###begin p 22
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 203 211 203 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1 </xref>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 441 445 441 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 554 558 554 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 600 606 600 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1042 1046 1042 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1212 1216 1212 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1306 1310 1306 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1378 1382 1378 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 9 17 <span type="species:ncbi:9606">children</span>
###xml 141 145 <span type="species:ncbi:9606">boys</span>
###xml 173 176 <span type="species:ncbi:9606">boy</span>
###xml 286 290 <span type="species:ncbi:9606">boys</span>
###xml 488 492 <span type="species:ncbi:9606">boys</span>
###xml 1315 1319 <span type="species:ncbi:9606">boys</span>
Among 65 children, who were referred for the evaluation of developmental delay, cognitive dysfunction, and behavioral problems, there were 4 boys with full mutation and one boy with premutation of FMR1. Table 1 shows the findings of molecular studies and clinical characteristics for 5 boys. Based on DNA analysis, this yielded a 6.15% positive rate of full mutation of FMR1. The mean age at the diagnosis of full mutation or premutation of FMR1 was 4.28 yr (range, 1.2-9.9 yr old). Four boys (case 1-4) showed methylated status in the CpG island of the FMR1 and had 200 or more CGG repeats of FMR1 (Fig. 1). Case 1 showed methylated status on the MS-PCR. The PCR using ABI PRISM 3100 Genetic Analyzer and Genescan did not show any peak, which indicated more than 230 repeats of CGG. The electrophoresis using 1.5% agarose gels showed full mutation in the range of 200-900. Although Southern blotting could not be done, because there was not enough DNA sample left for the procedure, these findings indicated that case 1 had full mutation of FMR1 with methylation. Case 5 did not show methylation on the MS-PCR, and the PCR analysis using ABI PRISM 3100 Genetic Analyzer and Genescan showed 58 repeats of CGG of FMR1, which indicated premutation according to our operant definition in which premutation of FMR1 for boys was diagnosed by the presence of 55-200 repeats of CGG in FMR1 and unmethylated CpG island.
###end p 22
###begin p 23
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 122 129 122 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 188 192 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 229 233 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 293 297 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 372 378 370 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 418 422 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 553 557 551 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 644 648 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 679 683 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 784 788 782 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 855 859 853 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
Among the 5 cases, the mothers in 4 cases (case 1, 2, 3 and 5) also underwent PCR for FMR1, and the findings are shown in Table 1. The mother of case 1 showed full mutation (29/>/=200) of FMR1. Case 2 who showed full mutation of FMR1 had his mother with premutation (43/108 repeats of CGG) of FMR1. His maternal grandmother had normal-sized alleles (28/43 repeats of CGG; Fig. 1-[2]-lane 7), therefore, the premutated FMR1 of the mother of case 2 could be transmitted from her father who had died from a motor vehicle accident 10 yr ago. The premutated FMR1 of the mother was transmitted to her son (case 2), which expanded to full mutation of FMR1. Case 3 with full mutation of FMR1 had the mother with premutation (33/82 repeats of CGG). The mother of case 5 who had premutation of FMR1 (58 repeats of CGG) showed premutation (28/ 56 repeats of CGG) of FMR1.
###end p 23
###begin p 24
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 98 105 98 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 34 38 <span type="species:ncbi:9606">boys</span>
###xml 56 59 <span type="species:ncbi:9606">boy</span>
###xml 454 462 <span type="species:ncbi:9606">children</span>
###xml 638 641 <span type="species:ncbi:9606">boy</span>
The clinical characteristics of 4 boys with FXS and the boy with premutation of FMR1 are shown in Table 1. As shown in the table, they all revealed significant cognitive dysfunction. Their birth weight and gestational period were within the normal range (3,290+/-625 g; 38.6+/-1.34 weeks). Some dysmorphic features were recognized such as large ears, pes planovalgus, high arched palate, macroglossia, and large hands with plenty of palmar creases. Five children all showed varying degrees of autistic behaviors and significant delay in language development. Brain MRI did not show remarkable structural abnormalities in all 5 cases. The boy with premutation (case 5) showed moderate mental retardation with SQ 48.4, severe drooling, microcephaly, short attention span, and gaze avoidance.
###end p 24
###begin title 25
Review of the literature
###end title 25
###begin p 26
###xml 70 71 70 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 108 115 108 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 327 331 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 438 442 438 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 570 574 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 585 590 <span type="species:ncbi:9606">women</span>
###xml 652 657 <span type="species:ncbi:9606">women</span>
Thirteen articles on FXS published in Korea since 1993 were reviewed (6-18) and its summary is presented in Table 2. The positive rate of FXS was in the range of 0.77-8.51%, depending on the study groups and the method of diagnosis (6, 8, 9, 11, 13-15, 17) The prevalence survey for 699 neonates showed 0.43% of premutation of FMR1 (16). There was a case report of prenatal diagnosis for the fetus from the mother of known premutation of FMR1, which showed that the fetus had full mutation of FMR1 (12). Song et al. reported the mean CGG repeat number (26.9 repeats) of FMR1 in Korean women (18), and Hur et al. detected premutation of FMR1 in 3.6% of women with idiopathic premature ovarian failure (10).
###end p 26
###begin title 27
DISCUSSION
###end title 27
###begin p 28
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 863 867 863 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 315 323 <span type="species:ncbi:9606">patients</span>
###xml 444 452 <span type="species:ncbi:9606">patients</span>
Here, we presented our case series of FXS with a review of the Korean literature on FXS. To the best of our knowledge, this is the first report on the use of MS-PCR for the diagnosis of FXS. In FXS, there are two special subclasses of mosaicism based on the size and methylation status. Size mosaics occur in those patients with both full mutation and premutation, a pattern that is detected in about 25% of male and in less than 10% of female patients. Methylation mosaics are those with variations between cells in the methylation status of a full mutation. The proportion of leucocytes with an unmethylated full mutation may vary from low (approximately 10%) to 100% (19, 20). Therefore, the use of MS-PCR in the molecular diagnosis of FXS should be complemented with the PCR and Southern blotting due to methylation mosaicism as well as size mosaicism of the FMR1.
###end p 28
###begin p 29
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
FXS has been found in many populations throughout the world. Many studies on the prevalence of FXS were carried out in the past by cytogenetic analysis (21), and similar studies are now being undertaken using DNA analysis. Nevertheless, there is relatively a few published on DNA-based FXS screening among different ethnic groups. The prevalence of FXS, based on DNA analysis of population samples, has been reported as 1/4,000 males and 1/6,000-8,000 females in western countries (22). Crawford et al. reported a higher point estimate of FXS for African-American males (1/2,545; 95% confidence interval [CI], 1/5,208-1/1,289) than reported previously, although CI include the prevalence for Caucasians estimated from this (1/3,717; 95% CI, 1/7,692-1/1,869) (23). With regard to the prevalence of FXS, there is always the possibility that founder effects (the founding group having an overrepresentation of relatively unstable alleles in the intermediate or premutation range) could result in some populations having a higher prevalence of FXS.
###end p 29
###begin p 30
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 671 672 671 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 677 678 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
Through the molecular diagnosis, Goldman et al. found FXS in 6.1% of 148 mentally retarded, black South African males (24), which is similar to our result. In Asia, Arinami et al. reported 8.6% of the positive rate of FXS among 152 male inmates population with unknown causes of mental retardation (25). In 1995, Lee et al. reported 8 cases of FXS (8.5%), and 9 cases of premutation (9.6%) out of 94 cases referred for the diagnosis of FXS in Korea, using the molecular diagnosis (14). According to the literature review, although there has yet been population-based prevalence study published in Korea, the positive rate of FXS appears to be in the range of 0.77-8.51% (6, 8, 9, 11, 13-15, 17), depending on the study subjects and the diagnostic methods. Therefore, this information does not seem to allow any conclusion on the prevalence of FXS among Korean population.
###end p 30
###begin p 31
###xml 765 766 763 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 895 897 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1247 1251 1245 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1264 1266 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1428 1430 1426 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1617 1621 1615 1619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1749 1753 1747 1751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 2147 2149 2145 2147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
In FXS, the transition from unmethylated moderate expansions of the CGG repeat (premutations) to methylated large expansions (full mutations) occurs only through maternal transmission. The timing of this transition was the subject of much speculation. Based on the observation that males with full mutation have premutation in sperm, a postzygotic transition was proposed as a preferred model. The risk of such transition is highly correlated with the size of the maternal premutation, being very low for small PM alleles (</=60 repeats) and 100% for alleles above 100 repeats. The American College of Medical Genetics (ACMG) in 2001 defined the lower bound of the premutation range at 55 CGG repeats, irrespective of nucleotide composition of the repeat sequence (5). The positive rate of premutation alleles >54 repeats in the general population is estimated at 1/259 females and 1/813 males (26). Smaller CGG repeats (~45-54 repeats) can also be associated with repeat length instability upon transmission, with the possibility of expanding to a full mutation. It has been reported that the smallest premutation alleles that expanded to a full mutation (>200 repeats) in one generation contained 59 repeats with no AGG interruptions within the FMR1 CGG repeat (27). In terms of premutation, besides the number of CGG repeats, the number of AGG interruptions within the CGG tract also plays a role in repeat-length stability (27). There is some evidence to indicate that the instability in both meiosis and mitosis depends critically on the length of pure CGG tracts within the 3' end of the array. The majority of FMR1 alleles have the CGG tract interrupted by regularly interspersed AGG triplets; every 10th, 11th, or 12th CGG repeat unit. Most FMR1 alleles are likely to be stable because either the total repeat length is less than 34 or there are sufficient interspersed AGGs to keep the pure 3' CGG tract below the 34 threshold. In vitro studies have shown that AGGs within a CGG tract can prevent the formation of the stable hairpin structures implicated in the replication slippage that is probably the immediate cause of the expansion (19). From the practical point of view, the distinction of normal-size alleles, intermediate-size alleles, and lower end of premutation seems to be not always clear, and it may be due to technical sensitivity as well as the presence of family history and repeat instability.
###end p 31
###begin p 32
###xml 441 445 441 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 604 608 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 700 704 700 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 866 870 866 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1281 1283 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 9 17 <span type="species:ncbi:9606">patients</span>
Although patients with FXS suffer from profound to borderline mental retardation, the presence of a methylated full mutation is routinely associated with their cognitive dysfunction. Nevertheless, no correlation is observed between the degree of MR and the size of the full mutation. The expansion size does not necessarily have an influence on the severity of the clinical phenotype in the males, presumably because hypermethylation of the FMR1 gene at a particular repeat-size threshold produces an 'all or none' effect. To the best of our knowledge, it is not clear whether the normal size alleles of FMR1 can produce functional FMRP or not, in the mosaics of full mutation/normal size alleles of FMR1. Further study on the assessment of FMRP level is required. In our case series of FXS, there was one mother with full mutation and 3 mothers with premutation of FMR1. Although the psychological evaluations for those mothers were not done, these mothers were regular high school or college graduates and denied any learning problems. Case 3 reported to have three maternal cousins with mental retardation. It is generally known that about 50% of heterozygous females with full mutation have some degree of learning difficulties due to inactivation of one of the X chromosomes (19).
###end p 32
###begin p 33
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 719 723 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1151 1153 1151 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1275 1277 1275 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1409 1413 1409 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 34 37 <span type="species:ncbi:9606">boy</span>
###xml 119 123 <span type="species:ncbi:9606">boys</span>
###xml 446 454 <span type="species:ncbi:9606">children</span>
###xml 485 489 <span type="species:ncbi:9606">boys</span>
###xml 641 645 <span type="species:ncbi:9606">boys</span>
###xml 924 932 <span type="species:ncbi:9606">children</span>
###xml 988 996 <span type="species:ncbi:9606">children</span>
###xml 1204 1212 <span type="species:ncbi:9606">children</span>
In our case series, there was one boy with premutation who showed severe clinical presentations indistinguishable from boys with full mutation. He had premutation with 58 CGG repeats, which was thought to be relatively low copy number. Besides the clinical effects of premutation in adults such as premature ovarian failure and fragile-X associated tremor ataxia syndrome (FXTAS), several studies show the presence of neurobehavioral symptoms in children (28). Esch identified several boys with premutation with learning problems, developmental delay and/or autistic features, and she identified four times more premutations in the group of boys younger than 16 yr old with developmental problems who were referred for FMR1 testing. Although larger and more longitudinal standardized studies are needed, these data provide further evidence that fragile X premutations may affect neurocognitive and behavioral functioning in children (29). Tassone et al. found lowered FMRP levels in some children with premutation who presented with mental retardation and/or autism, suggesting a spectrum of clinical severity associated with related protein deficit (30). Similar observation has also been reported in 5 children with diagnosis of autistic spectrum disorder and premutation (31). However, whether his clinical features including mental retardation and behavioral problems were related with his premutation of FMR1 or not is inconclusive at this point.
###end p 33
###begin p 34
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 616 624 <span type="species:ncbi:9606">children</span>
In our case series, the mean age at the diagnosis of FXS or premutation of FMR1 was 4.28 yr (range; 1.2-9.9 yr old). Most of Down syndrome cases are identified at birth on the basis of physical features; however, FXS is not at all obvious at birth. Usually, parents begin to notice behavioral problems or delayed attainment of developmental milestones. Sometimes, these signs are subtle and it may take a long time for a physician or other professional to acknowledge that a problem exists. Early identification of FXS remains important not only for genetic counseling and prenatal testing, but also for parents and children to explain their difficulties, thereby facilitating the access to educational and clinical services.
###end p 34
###begin p 35
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 415 423 <span type="species:ncbi:9606">children</span>
In our case series, brain MRI findings were not remarkable. Although brain weight and gross anatomy in FXS have been reported to be normal, there is, however, mounting evidence of morphological abnormalities of the brain in the FXS. Several structural MRI studies have reported reduced cerebellar vermis size and enlarged fourth ventricle in FXS individuals. An increase in caudate nucleus volume has been found in children with FXS (32, 33).
###end p 35
###begin p 36
Several limitations are noted in our current study, mainly due to its retrospective nature. Regardless of these limitations, however, it is believed that this case series might be able to add some valuable information to the body of knowledge of FXS in Korea.
###end p 36
###begin p 37
In summary, we presented four cases of FXS and one case of premutation with their clinical characteristics with a review of the literature.
###end p 37
###begin article-title 38
Fragile X syndrome
###end article-title 38
###begin article-title 39
Standardization of PCR amplification for fragile X trinucleotide repeat measurements
###end article-title 39
###begin article-title 40
A methylation PCR approach for detection of fragile X syndrome
###end article-title 40
###begin article-title 41
Diagnosis of Fragile X syndrome by Southern blot hybridization using a chemiluminescent probe: a laboratory protocol
###end article-title 41
###begin article-title 42
Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee
###end article-title 42
###begin article-title 43
###xml 42 50 <span type="species:ncbi:9606">Patients</span>
Incidence of Fragile X Syndrome in Korean Patients with Mental Retardation
###end article-title 43
###begin article-title 44
Fragile X Syndrome : Clinical Characteristics and EEG Findings
###end article-title 44
###begin article-title 45
###xml 29 34 <span type="species:ncbi:9606">child</span>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Chromosomal abnormalities in child psychiatric patients
###end article-title 45
###begin article-title 46
###xml 82 90 <span type="species:ncbi:9606">Children</span>
DNA Testing for Fragile X Syndrome in School for Emotionally Severely Handicapped Children in Korea
###end article-title 46
###begin article-title 47
###xml 25 33 <span type="species:ncbi:9606">Patients</span>
Fragile X Premutation in Patients with Idiopathic Premature Ovarian Failure
###end article-title 47
###begin article-title 48
###xml 51 59 <span type="species:ncbi:9606">Children</span>
Molecular Genetic Study for FMR-1 Gene in Autistic Children
###end article-title 48
###begin article-title 49
Prenatal Diagnosis of Fragile X Syndrome using Amniotic Fluid DNA
###end article-title 49
###begin article-title 50
###xml 67 75 <span type="species:ncbi:9606">children</span>
Molecular screening for fragile x syndrome in mentally handicapped children in Korea
###end article-title 50
###begin article-title 51
Molecular Genetics in Fragile X syndrome (1)
###end article-title 51
###begin article-title 52
###xml 48 52 <span type="species:ncbi:9606">boys</span>
Fragile site X chromosomes in mentally retarded boys
###end article-title 52
###begin article-title 53
A Study on Prevalence of Premutation Sized FMR1 Gene Using Polymerase Chain Reaction
###end article-title 53
###begin article-title 54
###xml 48 56 <span type="species:ncbi:9606">Children</span>
Etiological Classification of Mentally Retarded Children Enrolled in a Special Educational Institution
###end article-title 54
###begin article-title 55
###xml 43 48 <span type="species:ncbi:9606">women</span>
Allele distribution of FMR1 gene in Korean women
###end article-title 55
###begin article-title 56
An assessment of screening strategies for fragile X syndrome in the UK
###end article-title 56
###begin article-title 57
Mosaicism for a full mutation, premutation, and deletion of the CGG repeats results in 22% FMRP and elevated FMR1 mRNA levels in a high-functioning fragile X male
###end article-title 57
###begin article-title 58
Fragile-X syndrome in North East Essex: towards systematic screening: clinical selection
###end article-title 58
###begin article-title 59
Prevalence of fragile X syndrome
###end article-title 59
###begin article-title 60
Prevalence of the fragile X syndrome in African-Americans
###end article-title 60
###begin article-title 61
Molecular evidence that fragile X syndrome occurs in the South African black population
###end article-title 61
###begin article-title 62
Frequency of the fragile X syndrome in Japanese mentally retarded males
###end article-title 62
###begin article-title 63
Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome
###end article-title 63
###begin article-title 64
Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles
###end article-title 64
###begin article-title 65
A neuropsychological investigation of male premutation carriers of fragile X syndrome
###end article-title 65
###begin article-title 66
The Fragile X premutation: new insights and clinical consequences
###end article-title 66
###begin article-title 67
Clinical involvement and protein expression in individuals with the FMR1 premutation
###end article-title 67
###begin article-title 68
###xml 21 25 <span type="species:ncbi:9606">boys</span>
Clinical features of boys with fragile X premutations and intermediate alleles
###end article-title 68
###begin article-title 69
Neuroanatomical, molecular genetic, and behavioral correlates of fragile X syndrome
###end article-title 69
###begin article-title 70
Genetics of childhood disorders: XLVIII. Learning and memory, Part 1: Fragile X syndrome update
###end article-title 70
###begin p 71
The molecular diagnostic findings of fragile X syndrome.
###end p 71
###begin p 72
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
The molecular diagnostic findings and clinical characteristics of the cases with full mutation or premutation of FMR1
###end p 72
###begin p 73
###xml 138 144 <span type="species:ncbi:9606">infant</span>
MS-PCR, methylation-specific polymerase chain reaction; MDI PDI, the mental and psychomotor developmental indices of the Bayley scales of infant development-II; VIQ, verbal intelligence quotient; PIQ, performance intelligence quotient; SQ, social quotient; NL, normal findings.
###end p 73
###begin p 74
Review of the literature on fragile X syndrome published in Korea
###end p 74
###begin p 75
PCR, polymerase chain reaction; PDD, pervasive developmental disorder.
###end p 75

